Developer refused permission to raze €47 million mansion
Earlier this year, a company owned by Myles Crofton of Avenue Homes applied for permission to knock down the existing Renesca mansion on Cross Avenue, and construct 33 apartments on the site
A Celtic Tiger property developer who paid €47 million for the site on which he subsequently built a mansion in Blackrock in south Dublin during the boom has been refused permission to demolish the house.
Earlier this year, a company owned by Myles Crofton of Avenue Homes applied for permission to knock down the existing Renesca mansion on Cross Avenue, and construct 33 apartments on the site.
Crofton built Renesca roughly 12 years ago on the...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Susan O'Keeffe: This week showed the absolute need for lobbying when it serves the public interest
The best lobbying is upfront, sometimes naïve, always passionate and rooted in an injustice, as opposed to the type performed by David Cameron in defence of 'his' bank
'Public health consultants breathed a huge sigh of relief when mandatory hotel quarantine came in'
Fall in detections of 'variants of concern' has taken place since late March, when mandatory hotel quarantine was introduced
Neale Richmond: Events in Scotland could have a profound effect in Ireland
A border poll being called by the Secretary of State is no longer a remote possibility and another referendum in Scotland could well be the catalyst
Comment: Undermining patent incentive could deprive world of important medicines in the future
Waiving IP rights may threaten the patent system which has underpinned the extraordinary advances in science that delivered vaccines within a year of the pandemic beginning